Discover
GNLX
Genelux Corporation
2.90
2 x 2.17
2 x 3.69
bid
ask
-
0.11
3.65%
2 @ 04:00 PM
2.90 +0.00 (0.00%)
| Ytd | -33.49% | |
| 1y | 2.47% |
2.87
day range
3.05
2.29
52 week range
8.54
| Open | 3.03 | Prev Close | 3.01 | Low | 2.87 | High | 3.05 | Mkt Cap | 130.04M |
| Vol | 161.97K | Avg Vol | 190.03K | EPS | -0.85 | P/E | N/A | Forward P/E | -2.45 |
| Beta | N/A | Short Ratio | 8.90 | Inst. Own | 15.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 2.88 | 200-d Avg | 3.70 | 1yr Est | 18.40 |
GNLX News
benzinga.com
Genelux Announces Publication Of Translational And Clinical Findings From Phase 1b/2 VIRO-15 Trial O
- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversa
globenewswire.com
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherap
- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversa